Evaluation of the highly sensitive chemiluminescent enzyme immunoassay “Lumipulse <scp>HB</scp>sAg‐<scp>HQ</scp>” for hepatitis B virus screening

Abstract

According to these results, the Lumipulse HBsAg-HQ assay, with a highly sensitive limit of detection of 0.005 IU/mL, may facilitate the development of a better management strategy for a considerable proportion of infected patients.